ID
25651
Descripción
Study ID: 101468/228 Clinical Study ID: 101468/228 Study Title:A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363727 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Dyskinesias; Parkinson Disease; Parkinson's Disease Study part: Concomitant medications
Palabras clave
Versiones (4)
- 11/8/17 11/8/17 -
- 18/8/17 18/8/17 -
- 18/8/17 18/8/17 -
- 8/9/17 8/9/17 -
Subido en
8 de septiembre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Concomitant medications GSK study Dyskinesia in Parkinson's disease NCT00363727
Concomitant medications GSK study Dyskinesia in Parkinson's disease NCT00363727
Descripción
Concomitant medications
Descripción
If Yes, record each medication on a separate line using Trade Names where possible. If the medication is related to a Non-Serious Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2347852
Descripción
(Trade Name preferred)
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013227
Descripción
Total daily dose
Tipo de datos
float
Alias
- UMLS CUI [1]
- C2348070
Descripción
The following lists of abbreviations are examples which can be used to aid the completion of the appropriate items on the L-Dopa page.These are not all inclusive lists and are for guidance only, other abbreviations may be used if necessary. Abbreviation Label: TAB = Tablet, MCL = Microlitre, ML = Millilitre, L = Litre, MCG = Microgram, MG = Milligram, G = Gram
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0450442
- UMLS CUI [1,2]
- C1519795
Descripción
The following lists of abbreviations are examples which can be used to aid the completion of the appropriate items on the L-Dopa page.These are not all inclusive lists and are for guidance only, other abbreviations may be used if necessary. Abbreviation Label: IM = Intramuscular, IH = Inhalation, IV = Intravenous, NS = Nasal, TP = Topical, PO = Oral, VG = Vaginal
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0013153
Descripción
Reason for Medication
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2826696
Descripción
Start Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0808070
Descripción
Stop Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0806020
Descripción
Ongoing Medication
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826666
Similar models
Concomitant medications GSK study Dyskinesia in Parkinson's disease NCT00363727
C0678257 (UMLS CUI [1,2])
C1519795 (UMLS CUI [1,2])